Given the similarity of symptoms of side effects of IFN administration and PASC, we previously reported a case showing elevated type I IFN activity in a patient who had continuous internal viral shedding in the saphenous vein one month after clinical recovery from COVID-19 (10). The gene discussed is IFNA1; the disease is COVID-19.